Quaker Chemical Reports Strong Q4 2025 Results, Projects 2026 Growth

summarizeSummary

Quaker Chemical reported robust Q4 2025 results with strong growth in sales and non-GAAP earnings, despite a full-year GAAP net loss driven by one-time charges. The company also announced significant share repurchases and an optimistic outlook for 2026.

check_boxKey Events

• Strong Q4 2025 Performance

  Net sales increased 6% year-over-year to $468.5 million. Non-GAAP earnings per diluted share rose 24% to $1.65, and adjusted EBITDA grew 11% to $71.9 million, marking the second consecutive quarter of year-over-year profitability improvement.

• Full Year 2025 GAAP Net Loss Explained

  The company reported a full-year GAAP net loss of $2.5 million, or $0.14 per diluted share, which includes an $88.8 million impairment charge and $35.1 million in restructuring charges. Excluding these items, non-GAAP net income was $123.2 million, or $7.02 per diluted share.

• Significant Shareholder Returns

  In 2025, Quaker Chemical returned $75.9 million to shareholders, including $41.5 million through share repurchases of 364,797 shares, demonstrating a commitment to capital allocation.

• Optimistic 2026 Outlook

  Management anticipates end markets to remain at similar levels through the first half of 2026, with potential for incremental growth in the latter half, and is confident in delivering revenue and adjusted EBITDA growth for the full year 2026.

auto_awesomeAnalysis

Quaker Chemical Corporation announced a strong finish to 2025 with significant year-over-year improvements in its fourth-quarter financial performance. Net sales, non-GAAP net income, and adjusted EBITDA all saw healthy increases, indicating a positive operational trend. While the full year 2025 GAAP results showed a net loss, this was primarily due to substantial non-recurring impairment and restructuring charges. Management expressed confidence in delivering revenue and adjusted EBITDA growth in 2026, supported by new business wins and strategic acquisitions. The company also returned a significant amount of capital to shareholders through share repurchases and dividends, signaling financial health and commitment to shareholder value.